SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
The demonstration of a remote partial nephrectomy underscores the system's capabilities in telesurgery, a field that could expand access to specialized surgical care in underserved regions. The company's focus on affordability and accessibility aligns with the broader goal of democratizing robotic surgery. For more details, the full press release is available at https://ibn.fm/YYYKE.
SS Innovations International develops surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support various procedures including cardiac surgery. Headquartered in India as an American company, SS Innovations plans to expand its global presence with technologically advanced and cost-effective solutions.
The presentation at the Society of Robotic Surgery Annual Meeting highlights the growing interest in telesurgery and the potential for robotic systems to bridge healthcare gaps. With over 12,000 procedures performed and training provided to thousands of physicians, the SSi Mantra system is positioned as a key player in the evolving landscape of robotic surgery. The event provides a platform for discussing regulatory challenges and opportunities for wider adoption, which could influence future policies and investments in the field.
Forward-looking statements in this article involve risks and uncertainties, as detailed in the company's filings with the SEC. More information is available at http://IBN.fm/Disclaimer.
